글로벌 수면 무호흡 장치 시장 규모, 점유율 및 추세 분석 보고서 – 산업 개요 및 2031년까지의 예측

수면 무호흡증 장치 시장 분석

수면 무호흡증 장치 시장은 수면 무호흡증의 유병률 증가와 건강에 미치는 영향에 대한 인식 증가에 힘입어 상당한 성장을 경험하고 있습니다. 수면 중 호흡이 반복적으로 중단되는 수면 무호흡증은 전 세계적으로 수백만 명에게 영향을 미치며 효과적인 치료 솔루션에 대한 수요를 촉진합니다. 이 시장은 지속적 양압 호흡(CPAP) 기계, 구강 기구, 적응형 서보 환기(ASV) 장치 등 다양한 장치를 포함하며, 모두 환자 결과를 개선하는 것을 목표로 합니다. 기술의 발전과 같은 최근의 발전으로 인해 더욱 편안하고 사용하기 쉬운 장치가 생겨 환자의 준수도가 더욱 향상되었습니다. 또한 가정 건강 관리와 원격 진료에 대한 강조가 커지면서 수면 무호흡증 진단 및 치료에 대한 접근성이 확대되고 있습니다. 의료 서비스 제공자가 개인화된 치료를 우선시함에 따라 시장은 지속적인 혁신을 보일 것으로 예상되며, 수면 무호흡증 장치는 영향을 받는 개인의 더 나은 수면 건강과 전반적인 삶의 질을 증진하는 데 필수적입니다.

수면 무호흡증 장치 시장 규모

글로벌 수면 무호흡증 장치 시장 규모는 2023년에 44억 4천만 달러로 평가되었으며, 2031년까지 80억 4천만 달러에 도달할 것으로 예상되며, 2024년에서 2031년까지의 예측 기간 동안 CAGR은 7.70%입니다. Data Bridge Market Research에서 큐레이팅한 시장 보고서에는 시장 가치, 성장률, 세분화, 지리적 범위, 주요 업체와 같은 시장 시나리오에 대한 통찰력 외에도 심층 전문가 분석, 환자 역학, 파이프라인 분석, 가격 분석 및 규제 프레임워크도 포함됩니다.

수면 무호흡증 장치 시장 동향

“ 휴대용 및 가정용 수면 무호흡증 장치 개발”

수면 무호흡증 장치 시장은 혁신적인 기술과 변화하는 소비자 선호도에 힘입어 빠르게 진화하고 있습니다. 이 분야의 중요한 추세는 환자의 접근성과 편의성을 향상시키는 휴대용 및 가정용 수면 무호흡증 장치의 개발입니다. 소형 CPAP 기계와 착용형 모니터링 도구를 포함한 이러한 장치는 집에서 편안하게 수면 무호흡증을 더 쉽게 관리하여 치료 준수도를 높입니다. 스마트폰 통합의 혁신으로 실시간 모니터링 및 의료 서비스 제공자와의 데이터 공유가 가능해져 개인화된 치료 계획이 용이해지고 있습니다. 수면 무호흡증에 대한 인식이 계속 증가함에 따라 이러한 발전은 시장을 변화시켜 더 광범위한 환자가 효과적인 치료를 더 쉽게 받을 수 있게 할 것으로 예상됩니다.

보고서 범위 및 수면 무호흡 장치 시장 세분화        

수면 무호흡 장치 시장 정의

Sleep apnea devices are medical equipment designed to diagnose and treat sleep apnea, a condition characterized by repeated interruptions in breathing during sleep. These devices include Continuous Positive Airway Pressure (CPAP) machines, which deliver a steady stream of air to keep the airway open, as well as oral appliances that reposition the jaw to prevent airway blockage. Other types of devices may include adaptive servo-ventilation (ASV) machines, which adjust pressure based on detected breathing patterns, and portable monitors that help in diagnosing the condition at home.

Sleep Apnea Devices Market Dynamics

Drivers

• Increasing Prevalence of Diagnosed Sleep Apnea

The increasing prevalence of diagnosed sleep apnea cases, especially among adults and the elderly, significantly drives the demand for effective treatment options in the market. As awareness of sleep apnea's associated health risks, such as cardiovascular diseases, diabetes, and hypertension, grows, more individuals are seeking diagnosis and intervention. The aging population is particularly vulnerable to sleep apnea due to physiological changes and the higher likelihood of comorbidities, leading to more healthcare professionals recommending screening and treatment. Consequently, this surge in diagnosed cases is stimulating the market for sleep apnea devices, such as Continuous Positive Airway Pressure (CPAP) machines and oral appliances, which are essential for managing the condition and improving the quality of life for affected individuals.

• Integration of Telemedicine

The integration of telemedicine in sleep apnea management is revolutionizing patient care by enabling remote monitoring and consultations, which in turn drives the adoption of sleep apnea devices. This technological advancement allows healthcare providers to monitor patients' progress in real-time, making it easier to adjust treatment plans based on individual needs. Patients can access specialized care from the comfort of their homes, reducing the barriers associated with traditional in-person visits. In addition, telemedicine offers convenience and flexibility, particularly for those in rural or underserved areas, enhancing overall treatment adherence. As healthcare systems continue to embrace digital solutions, the demand for sleep apnea devices, including CPAP machines and portable monitoring tools, is expected to rise, ultimately improving patient outcomes and quality of life.

Opportunities

• Advancement of  Innovative Therapies

Expanding the product range to include innovative therapies presents a significant growth opportunity in the sleep apnea devices market. By introducing non-invasive devices, such as positional therapy systems and adaptive servo-ventilation machines, manufacturers can cater to patients who may be uncomfortable with traditional Continuous Positive Airway Pressure (CPAP) machines. In addition, the development of combination therapies that integrate various treatment modalities—like oral appliances paired with behavioral therapies—can address the diverse needs of individuals suffering from sleep apnea. This diversification attracts a broader audience and  enhances treatment options for varying severities and types of sleep apnea, ultimately improving patient compliance and outcomes. As the market evolves, companies that prioritize innovation in their product offerings will be well-positioned to capitalize on this growing demand.

• Introduction of Smart Devices

Advancements in technology are creating significant opportunities for innovation in the sleep apnea devices market. The introduction of smart devices equipped with sensors can provide real-time monitoring of patients' sleep patterns and respiratory parameters, allowing for immediate adjustments to treatment plans. AI-driven monitoring systems can analyze vast amounts of data to identify trends and predict potential issues, enhancing the personalization of therapies. Enhanced data analytics can also improve the understanding of individual patient responses to different treatments, enabling healthcare providers to tailor interventions for optimal effectiveness. These technological innovations lead to more effective and personalized sleep apnea treatments and enhance patient engagement and adherence to therapy. Companies that leverage these advancements will be well-positioned to capture a larger share of the growing market.

Restraints/Challenges

• High Costs of Equipment

The inspire sleep apnea device cost is high, particularly Continuous Positive Airway Pressure (CPAP) machines and their associated accessories, poses a significant challenge in the market. Many patients require these essential tools to manage their condition effectively, but the financial burden can deter them from making a purchase. This issue is especially pronounced in regions with limited healthcare funding, where patients may struggle to afford necessary medical equipment without insurance coverage or assistance programs. The expense associated with sleep apnea devices limits access for patients and hinders overall treatment compliance, as individuals may choose to forgo therapy altogether. As a result, the market faces a critical challenge in ensuring that effective and affordable solutions are available to those in need, ultimately impacting patient outcomes.

•  Shortage of Qualified Healthcare Professionals

A significant restraint in the sleep apnea devices market is the shortage of qualified healthcare professionals capable of diagnosing and managing the condition effectively. This lack of expertise can severely limit patient access to necessary care and appropriate devices, as individuals may find it challenging to receive timely evaluations and treatment recommendations. Without adequate healthcare providers, many patients may remain undiagnosed or experience delays in receiving effective interventions, which can hinder their overall health and well-being. This shortage restricts the potential patient pool for sleep apnea devices and affects adherence to treatment plans, as proper management often requires continuous monitoring and support from healthcare professionals. Consequently, the limited availability of trained specialists poses a significant barrier to market growth and effective management of sleep apnea.

This market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Sleep Apnea Devices Market Scope

The market is segmented on the basis of diseases type, type, patient demographics, end-user, and distribution channel. The growth amongst these segments will help you analyse meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Diseases Type

• Obstructive Sleep Apnea Syndrome
• Central Sleep Apnea Syndrome
• Complex Sleep Apnea Syndrome

Type

• Devices
  • Actigraphs
  • Polysomnography (PSG) device
  • Respiratory Polygraphs
  • Pulse Oximeters
• Therapy
  • Positive Airway Pressure (PAP) Devices
  • CPAP
  • APAP
  • Bi-PAP
  • Oral Devices
  • Nasal Devices
  • Chin Straps

Patient Demographics

• Pediatric
• Adult
• Geriatric

End-User

• Hospitals/Clinics
• Diagnostic Centers
• Ambulatory Care Centers
• Specialty Care Centers
• Home Healthcare

Distribution Channel

• Direct Tender
• Retail Sales

 Sleep Apnea Devices Market Regional Analysis

The market is analysed and market size insights and trends are provided by country, diseases type, type, patient demographics, end-user, and distribution channel as referenced above.

The countries covered in the market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America leads the global sleep apnea devices market in terms of both revenue and market share, a trend expected to continue through 2030. This dominance is driven by increased investment in research and development, rising government initiatives, and advancements in healthcare infrastructure across the region. The combination of these factors positions North America as a key player in the market's growth trajectory.

Asia-Pacific is anticipated to experience the highest growth rate in the global sleep apnea devices market from 2024 to 2031. This growth is fueled by increasing government investments in the healthcare sector, coupled with rising technological advancements and supportive government initiatives. These factors are driving significant market expansion in the region.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.  

Sleep Apnea Devices Market Share

The market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to market.

Sleep Apnea Devices Market Leaders Operating in the Market Are:

• NIHON KOHDEN CORPORATION (Japan)
• Koninklijke Philips N.V. (Netherlands)
• General Electric Company (U.S.)
• Siemens (Germany)
• Natus (U.S.)
• Compumedics Limited (Australia)
• Magstim (U.S.)
• Advanced Brain Monitoring, Inc. (U.S.)
• B. Braun SE (Germany)
• BD (U.S.)
• Medical Device Business Services, Inc. (U.S.)
• Cadwell Industries, Inc. (U.S.)
• Masimo (U.S.)
• Elekta (Sweden)
• 인테그라 라이프사이언스 코퍼레이션(미국)
• Rimed Inc. (이스라엘)
• 요코가와 전기 주식회사(일본)
• 에모티브(미국)

수면 무호흡 장치 시장의 최신 개발

• 2024년 5월, NovaResp Technologies는 cMAP 양압 호흡 소프트웨어에 대한 임상 시험을 지원하기 위해 시드 확장 라운드에서 300만 달러를 확보했습니다. 이 자금은 수면 무호흡증 치료 개선을 목표로 하는 혁신적인 솔루션 개발을 가속화할 것입니다.
• 2024년 2월, EnsoData는 수면 장애 진단을 위해 설계된 AI 기반 EnsoSleep 알고리즘에 대한 FDA 승인을 받았습니다. 이 승인은 인공 지능을 사용하여 정확하고 효율적인 수면 장애 평가를 제공하는 EnsoSleep의 역량을 향상시킵니다.
• 2024년 2월, 마운트 시나이 연구자들은 폐쇄성 수면 무호흡증의 부작용을 예측하는 AI 기반 모델을 개발하고 연구하기 위해 400만 달러의 자금을 확보했습니다. 이 이니셔티브는 더 나은 진단 및 위험 평가를 위해 고급 AI 기술을 활용하여 환자 치료를 개선하는 것을 목표로 합니다.
• 2023년 11월, Vivos Therapeutics는 심각한 폐쇄성 수면 무호흡증(OSA)이 있는 성인을 위해 설계된 CARE(Complete Airway Repositioning and/or Expansion) 구강 장치에 대한 FDA 510(k) 승인을 받았습니다. 이 승인에는 회사의 주요 DNA, mRNA 및 mmRNA 구강 기구가 포함되어 OSA 환자의 치료 옵션을 확대하는 데 있어 중요한 이정표를 세웠습니다.
• 2023년 10월, ResMed는 Bittium Corporation의 자회사인 Bittium Biosignals Ltd와 협력하여 고급 가정용 수면 무호흡증 검사 및 분석 솔루션인 Bittium Respiro를 배포했습니다. 이 계약에는 Respiro 측정 장치, 액세서리 및 Respiro Analyst 소프트웨어 플랫폼이 포함되어 있으며 노르웨이, 영국, 스위스, 아일랜드, 핀란드, 스웨덴과 같은 국가를 포함합니다. 이 비독점적 거래는 수면 무호흡증 시장에서 ResMed의 포트폴리오를 강화합니다.

SKU-1403